MAPK1 and melanoma: The analysis of the BRAFV600E/NRAS melanoma mouse model showed an unexpected finding related to the effect of BRAF inhibitors in these cells: in fact, BRAF inhibitors induce RAS-dependent binding of BRAF to CRAF, consequent activation first of CRAF and then of MEK-ERK signaling [13].